Stemgent (iPS Cell Business Unit) is Laboratory Services (Healthcare) in United States that focus on cell research business. They cover business area such as Provider, iPS cell research service, cell research reagent product, mrna reprogramme kit, xeno-free culture medium, specialty chemical, cell differentiation.
Laboratory Services (Healthcare)
-
Cell Research
-
One Kendall Square, Street 2
Suite B6201
Cambridge, MA 02139
United States
Private
ProvideriPS cell research servicecell research reagent productmrna reprogramme kitxeno-free culture mediumspecialty chemicalcell differentiation
* We use standard office opening hours in near Stemgent (iPS Cell Business Unit)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Stemgent (iPS Cell Business Unit) is Laboratory Services (Healthcare) business from United States that founded in - ( years old in ), Stemgent (iPS Cell Business Unit) business is focusing on Cell Research.
Stemgent (iPS Cell Business Unit) headquarter office and corporate office address is located in One Kendall Square, Street 2 Suite B6201 Cambridge, MA 02139 United States.
Stemgent (iPS Cell Business Unit) was founded in United States.
In , Stemgent (iPS Cell Business Unit) is currently focus on cell research sector.
Above is snippet of Google Trends for "cell research" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Stemgent (iPS Cell Business Unit), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
